PRESS RELEASES
DEY® Press Room If you are a member of the media and would like more information about DEY, L.P., please contact our Public Affairs Department at Mylan, our parent company, at 724-514-1968. DEY® Press Releases Florida EMS and Fire Vehicles to Stock Cyanokit® 5g (hydroxocobalamin for injection) ANTIDOTE (“Cyanokit”) for Cyanide Poisoning May 29, 2008 Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone May 20, 2008 Nebulized Formoterol Fumarate Has Comparable Pharmacokinetic and Pharmacodynamic Profile to Dry Powder Formulation May 20, 2008 Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD PatientsMay 20, 2008 Clinical Trial Data for Perforomist™ Inhalation Solution to be Presented at ATS on May 20, 2008 May 16, 2008 More >>
If you are a member of the media and would like more information about DEY, L.P., please contact our Public Affairs Department at Mylan, our parent company, at 724-514-1968.
Florida EMS and Fire Vehicles to Stock Cyanokit® 5g (hydroxocobalamin for injection) ANTIDOTE (“Cyanokit”) for Cyanide Poisoning May 29, 2008
Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone May 20, 2008
Nebulized Formoterol Fumarate Has Comparable Pharmacokinetic and Pharmacodynamic Profile to Dry Powder Formulation May 20, 2008
Concomitant Treatment With Nebulized Formoterol Fumarate and Tiotropium Provides Clinically Significant Improvements for COPD PatientsMay 20, 2008
Clinical Trial Data for Perforomist™ Inhalation Solution to be Presented at ATS on May 20, 2008 May 16, 2008
